Cancer Chemotherapy and Pharmacology,volume 59,issue 2  (02-2007)

Period of time: 2007年2期

Publisher: Springer Publishing Company

Founded in: 1978

Total resources: 46

ISSN: 0344-5704

Subject: R73 Oncology

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Cancer Chemotherapy and Pharmacology,volume 59,issue 2

Menu

Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells

By Müller Christine,Gross Dietmar,Sarli Vasiliki,Gartner Michael,Giannis Athanassios,Bernhardt Günther,Buschauer Armin in (2007)

Cancer Chemotherapy and Pharmacology,volume 59,issue 2 , Vol. 59, Iss. 2, 2007-02 , pp. 157-164

Springer Publishing Company

Abstract Access to resources Recommend Favorite

A phase II, pharmacokinetic, and biologic study of semaxanib and thalidomide in patients with metastatic melanoma

By Mita Monica,Rowinsky Eric,Forero Leonardo,Eckhart S.,Izbicka Elzbieta,Weiss Geoffrey,Beeram Muralidhar,Mita Alain,Bono Johann,Tolcher Anthony,Hammond Lisa,Simmons Paul,Berg Kristin,Takimoto Chris,Patnaik Amita in (2007)

Cancer Chemotherapy and Pharmacology,volume 59,issue 2 , Vol. 59, Iss. 2, 2007-02 , pp. 165-174

Springer Publishing Company

Abstract Access to resources Recommend Favorite

A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade™), in combination with paclitaxel and carboplatin in patients with advanced malignancies

By Ma Cynthia,Mandrekar Sumithra,Alberts Steven,Croghan Gary,Jatoi Aminah,Reid Joel,Hanson Lorelei,Bruzek Laura,Tan Angelina,Pitot Henry,Erlichman Charles,Wright John,Adjei Alex in (2007)

Cancer Chemotherapy and Pharmacology,volume 59,issue 2 , Vol. 59, Iss. 2, 2007-02 , pp. 207-215

Springer Publishing Company

Abstract Access to resources Recommend Favorite